Nongenital Warts Treatment & Management
- Author: Philip D Shenefelt, MD, MS; Chief Editor: William D James, MD more...
Medical Care
Multiple modalities are available for the treatment of warts, but none is uniformly effective.[8, 9] Start with the least painful, least expensive, and least time-consuming methods. Reserve the more expensive and invasive procedures for refractory extensive warts. Immunosuppressed individuals often are refractory to wart treatments. Various treatment methods are available.
Benign neglect
Providing no treatment at all is certainly safe and cost effective. Consider this as an option, since 65% of warts may regress spontaneously within 2 years. Without treatment, however, patients risk warts that may enlarge or spread to other areas. Treatment is recommended for patients with extensive, spreading, or symptomatic warts or warts that have been present for more than 2 years.
Topical agents
Salicylic acid is a first-line therapy used to treat warts. It is available without a prescription and can be applied by the patient at home. Cure rates from 70-80% are reported.
British, nonblinded, randomized controlled trial compared treatment of plantar warts with 50% salicylic acid topical (Verrugon) applied daily with cryotherapy with liquid nitrogen (up to 4 treatments 2-3 wk apart). The study found no significant difference between the treatments in clearance of the plantar warts at 12 weeks and again at 6 months.[10] The lesser cost of the salicylic acid topical treatment made it more cost-effective than the liquid nitrogen treatment.
Several topical agents are available that can be applied by trained personnel in a physician's office. Cantharidin is an extract of the blister beetle that causes epidermal necrosis and blistering. Dibutyl squaric acid, also known as squaric acid dibutyl ester (SADBE), and diphencyclopropenone (DCP) are contact sensitizers. Trichloroacetic acid is a caustic compound that causes tissue necrosis. Podophyllin is a cytotoxic compound used more commonly in the treatment of genital warts. Aminolevulinic acid (ALA) is a photosensitizer that has been successfully used topically in combination with blue light to treat flat warts.[11]
Several prescription medications have proven beneficial in treating warts. These can be applied at home by the patient. Imiquimod is an immune response modifier approved for the treatment of genital warts. Reports indicate successful treatment of common warts.[12]
Cidofovir is an antiviral agent used for the treatment of cytomegalovirus infection in HIV patients. Reportedly, in 2 patients with recurrent persistent common warts in whom multiple standard therapies were not responsive, the warts were resolved using topical cidofovir gel applied 1-2 times per day. This remains an investigational drug for warts.[13]
Podophyllotoxin is a purified ingredient of podophyllin. Since it tends to work better on mucosal surfaces, it is used primarily to treat genital warts. Little information is available regarding treatment of nongenital warts with this medication.
5-Fluorouracil is a topical chemotherapeutic agent primarily used to treat actinic keratoses. It has been reported to be effective in treating warts when used under occlusion daily for up to 1 month. It has been used in children.[14]
Tretinoin is a topical retinoic acid that primarily is used to treat acne. It has been successful in treating flat warts.
Intralesional injections
When warts are persistent and refractory to topical agents, consider intralesional injections as an alternative.
Intralesional immunotherapy using injections of Candida, mumps, or Trichophyton skin test antigens has been shown to be effective in the treatment of warts, with reports of success in up to 74% of patients.[15] (A clinical trial recruiting as of May 5, 2009 is Study With Candida Antigen for Treatment of Warts.)
Bleomycin is a chemotherapeutic agent that inhibits DNA synthesis in cells and viruses. Cure rates have ranged from 33-92%.[16, 17]
Interferon-alfa is a naturally occurring cytokine with antiviral, antibacterial, anticancer, and immunomodulatory effects. Cure rates of 36-63% have been reported.
Photodynamic therapy
In one study, photodynamic therapy with topical 5-aminolevulinic acid applied to the warts,
followed by photoactivation with red 633-nm light-emitting diodes at 2- to 3-week
intervals resulted in 68% improvement.[18] .
Systemic agents
Systemic agents that have been used to treat warts include cimetidine, retinoids, and intravenous cidofovir.
Cimetidine is a type-2 histamine receptor antagonist commonly used to treat peptic ulcer disease. Because of its immunomodulatory effects at higher doses, cimetidine was considered a possible treatment for warts; however, results have varied. Double-blind placebo-controlled studies have shown no benefit.[19]
Retinoids are synthetic vitamin A analogs that may help with extensive disabling hyperkeratotic warts in immunocompromised patients. They may help alleviate pain and facilitate the use of other treatments. Retinoids also have helped reduce the number of lesions in immunosuppressed renal transplant patients. The limiting side effects include liver function abnormalities, increased serum lipid levels, and teratogenicity. (A clinical trial recruiting as of May 5, 2009 is bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients.)
Two reports have described intravenous cidofovir used for the treatment of extensive, disfiguring, and refractory warts. This should be used with caution because of the risk of nephrotoxicity.[20, 21]
Alternative treatments
Several alternative treatments have been reported as successful in treating warts, including adhesiotherapy, hypnosis, hyperthermia, garlic, and vaccines.[22, 23]
Adhesiotherapy is performed by applying duct tape to the wart daily. This method is painless and inexpensive and has reports of good success.
Hypnosis has been used to treat refractory warts.[24] Several published studies have documented the success of hypnotherapy. Cure rates have been reported from 27-55%, with prepubertal children more likely to respond than adults. Patients in whom hypnotherapy fails may respond to hypnoanalysis for warts.
Hyperthermia involves immersing the involved surface in hot water (113ºF) for 30-45 minutes, 2-3 times per week.
Propolis has been reported to be significantly more effective than Echinacea or placebo as an immunomodulating treatment for common and planar warts.[25]
Raw garlic cloves have been demonstrated to have antiviral activity. This can be rubbed onto the wart nightly, followed by occlusion.[26]
Tea tree oil applied topically has also been reported as successful.[27]
Vaccines currently are in development.
Surgical Care
Cryosurgery [28]
Liquid nitrogen (-196ºC) is the most effective method of cryosurgery. Apply liquid nitrogen using a cotton bud applicator or cryospray to the recommended 1-2 mm rim of normal skin tissue around the wart. Repeat every 1-4 weeks for approximately 3 months, as needed. Warn patients about pain and possible blistering after treatment.
Use with caution on the sides of fingers, since it can injure underlying structures and nerves. Other side effects may include scarring, ulceration, or pigment alteration. Cure rates of 50-80% have been reported. Paring the wart, in addition to 2 freeze-thaw cycles, has been a valuable adjunct to cryosurgery for plantar warts.[29]
Lasers
This is an expensive treatment, and is reserved only for large or refractory warts. Multiple treatments may be required. Local or general anesthesia may be necessary. A potential risk of nosocomial infection also exists in health care workers, since HPV can be isolated in the plume and can be inhaled.[30]
Carbon dioxide lasers have successfully treated resistant warts; however, the procedure can be painful and leave scarring. One retrospective study revealed a cure rate of 64% at 12 months with carbon dioxide lasers.[31]
The flashlamp-pumped pulse dye laser has shown mixed results in treating warts, with decreased risk of scarring and transmission of HPV in the smoke plume.[32]
Nd:YAG laser may be used for deeper, larger warts.
Electrodesiccation/curettage and surgery
Although electrodesiccation and curettage may be more effective than cryosurgery, it is painful, more likely to scar, and HPV can be isolated from the plume. Avoid using surgical excision in most circumstances because of the risks of scarring and recurrence.
Cohen PR, Hebert AA, Adler-Storthz K. Focal epithelial hyperplasia: Heck disease. Pediatr Dermatol. Sep 1993;10(3):245-51. [Medline].
Guadara J, Sergi A, Labruna V, Welch M, Gazivoda PL. Transformation of plantar verruca into squamous cell carcinoma. J Foot Surg. Nov-Dec 1992;31(6):611-4. [Medline].
Kolker AR, Wolfort FG, Upton J, Tahan SR, Hein KD, Zewert TE. Plantar verrucous carcinoma following transmetatarsal amputation and renal transplantation. Ann Plast Surg. May 1998;40(5):515-9. [Medline].
Noel JC, Detremmerie O, Peny MO, et al. Transformation of common warts into squamous cell carcinoma on sun-exposed areas in an immunosuppressed patient. Dermatology. 1994;189(3):308-11. [Medline].
Mallory SB, Baugh LS, Parker RK. Warts in blacks versus whites. Pediatr Dermatol. Mar 1991;8(1):91. [Medline].
Silverberg NB. Human papillomavirus infections in children. Curr Opin Pediatr. Aug 2004;16(4):402-9. [Medline].
Holland TT, Weber CB, James WD. Tender periungual nodules. Myrmecia (deep palmoplantar warts). Arch Dermatol. Jan 1992;128(1):105-6, 108-9. [Medline].
Bellew SG, Quartarolo N, Janniger CK. Childhood warts: an update. Cutis. Jun 2004;73(6):379-84. [Medline].
Goldfarb MT, Gupta AK, Gupta MA, Sawchuk WS. Office therapy for human papillomavirus infection in nongenital sites. Dermatol Clin. Apr 1991;9(2):287-96. [Medline].
Cockayne S, Hewitt C, Hicks K, et al. Cryotherapy versus salicylic acid for the treatment of plantar warts (verrucae): a randomised controlled trial. BMJ. Jun 7 2011;342:d3271. [Medline]. [Full Text].
Mizuki D, Kaneko T, Hanada K. Successful treatment of topical photodynamic therapy using 5-aminolevulinic acid for plane warts. Br J Dermatol. Nov 2003;149(5):1087-8. [Medline].
Perrett CM, Harwood C, Brown V. Topical 5% imiquimod treatment for refractory cutaneous warts. J Am Acad Dermatol. 2004;50(3):P41.
Roark TR, Pandya AG. Combination therapy of resistant warts in a patient with AIDS. Dermatol Surg. Dec 1998;24(12):1387-9. [Medline].
Gladsjo JA, Alio Saenz AB, Bergman J, Krikorian G, Cunninghan BB. 5% 5-fluorouracil cream for treatment of verruca vulgaris in children. Pediat Dermatol. 2009;26:279-285.
Horn TD, Johnson SM, Helm RM, Roberson PK. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. Arch Dermatol. May 2005;141(5):589-94. [Medline].
James MP, Collier PM, Aherne W, et al. Histologic, pharmacologic, and immunocytochemical effects of injection of bleomycin into viral warts. J Am Acad Dermatol. Jun 1993;28(6):933-7. [Medline].
Munn SE, Higgins E, Marshall M, Clement M. A new method of intralesional bleomycin therapy in the treatment of recalcitrant warts. Br J Dermatol. Dec 1996;135(6):969-71. [Medline].
Ohtsuki A, Hasegawa T, Hirasawa Y, Tsuchihashi H, Ikeda S. Photodynamic therapy using light-emitting diodes for the treatment of viral warts. J Dermatol. 2009;36:525-528.
Yilmaz E, Alpsoy E, Basaran E. Cimetidine therapy for warts: a placebo-controlled, double-blind study. J Am Acad Dermatol. Jun 1996;34(6):1005-7. [Medline].
Kottke MD, Parker SR. Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection. J Am Acad Dermatol. Sep 2006;55(3):533-6. [Medline].
Zabawski EJ Jr, Sands B, Goetz D, Naylor M, Cockerell CJ. Treatment of verruca vulgaris with topical cidofovir. JAMA. Oct 15 1997;278(15):1236. [Medline].
Focht DR 3rd, Spicer C, Fairchok MP. The efficacy of duct tape vs cryotherapy in the treatment of verruca vulgaris (the common wart). Arch Pediatr Adolesc Med. Oct 2002;156(10):971-4. [Medline].
[Best Evidence] Wenner R, Askari SK, Cham PM, Kedrowski DA, Liu A, Warshaw EM. Duct tape for the treatment of common warts in adults: a double-blind randomized controlled trial. Arch Dermatol. Mar 2007;143(3):309-13. [Medline].
Ewin DM. Hypnotherapy for warts (verruca vulgaris): 41 consecutive cases with 33 cures. Am J Clin Hypn. Jul 1992;35(1):1-10. [Medline].
Zedan H, Hofney ERM, Ismail SA. Propolis as an alternative treatment for cutaneous warts. Internat J Dermatol. 2009;48:1246-1249.
Silverberg NB. Garlic cloves for verruca vulgaris. Pediatr Dermatol. Mar-Apr 2002;19(2):183. [Medline].
Millar BC, Moore JE. Successful topical treatment of hand warts in a paediatric patient with tea tree oil (Melaleuca alternifolia). Complement Ther Clin Pract. Nov 2008;14(4):225-7. [Medline].
Bourke JF, Berth-Jones J, Hutchinson PE. Cryotherapy of common viral warts at intervals of 1, 2 and 3 weeks. Br J Dermatol. Mar 1995;132(3):433-6. [Medline].
Berth-Jones J, Hutchinson PE. Modern treatment of warts: cure rates at 3 and 6 months. Br J Dermatol. Sep 1992;127(3):262-5. [Medline].
Gloster HM Jr, Roenigk RK. Risk of acquiring human papillomavirus from the plume produced by the carbon dioxide laser in the treatment of warts. J Am Acad Dermatol. Mar 1995;32(3):436-41. [Medline].
Sloan K, Haberman H, Lynde CW. Carbon dioxide laser-treatment of resistant verrucae vulgaris: retrospective analysis. J Cutan Med Surg. Jan 1998;2(3):142-5. [Medline].
Hughes PS, Hughes AP. Absence of human papillomavirus DNA in the plume of erbium:YAG laser-treated warts. J Am Acad Dermatol. Mar 1998;38(3):426-8. [Medline].
Rivera A, Tyring SK. Therapy of cutaneous human Papillomavirus infections. Dermatol Ther. 2004;17(6):441-8. [Medline].
Androphy EJ. Human papillomavirus. Current concepts. Arch Dermatol. May 1989;125(5):683-5. [Medline].
Baker GE, Tyring SK. Therapeutic approaches to papillomavirus infections. Dermatol Clin. Apr 1997;15(2):331-40. [Medline].
Benton EC. Therapy of cutaneous warts. Clin Dermatol. May-Jun 1997;15(3):449-55. [Medline].
Bouwes Bavinck JN, Berkhout RJ. HPV infections and immunosuppression. Clin Dermatol. May-Jun 1997;15(3):427-37. [Medline].
Cobb MW. Human papillomavirus infection. J Am Acad Dermatol. Apr 1990;22(4):547-66. [Medline].
Drake LA, Ceilley RI, Cornelison RL, et al. Guidelines of care for warts: human papillomavirus. Committee on Guidelines of Care. J Am Acad Dermatol. Jan 1995;32(1):98-103. [Medline].
Jablonska S, Majewski S, Obalek S, Orth G. Cutaneous warts. Clin Dermatol. May-Jun 1997;15(3):309-19. [Medline].
Kilkenny M, Marks R. The descriptive epidemiology of warts in the community. Australas J Dermatol. May 1996;37(2):80-6. [Medline].
Matsukura T, Iwasaki T, Kawashima M. Molecular cloning of a novel human papillomavirus (type 60) from a plantar cyst with characteristic pathological changes. Virology. Sep 1992;190(1):561-4. [Medline].
Melton JL, Rasmussen JE. Clinical manifestations of human papillomavirus infection in nongenital sites. Dermatol Clin. Apr 1991;9(2):219-33. [Medline].
Schachner L, Ling NS, Press S. A statistical analysis of a pediatric dermatology clinic. Pediatr Dermatol. Oct 1983;1(2):157-64. [Medline].
Siegfried EC. Warts on children: an approach to therapy. Pediatr Ann. Feb 1996;25(2):79-90. [Medline].
Yanagihara M, Sumi A, Mori S. Papillomavirus antigen in the epidermoid cyst of the sole. Immunohistochemical and ultrastructural study. J Cutan Pathol. Dec 1989;16(6):375-81. [Medline].
Young R, Jolley D, Marks R. Comparison of the use of standardized diagnostic criteria and intuitive clinical diagnosis in the diagnosis of common viral warts (verrucae vulgaris). Arch Dermatol. Dec 1998;134(12):1586-9. [Medline].

